Danaher's quarterly results show signs of life, and the struggling stock soars

Danaher shares on Tuesday climbed more than 6% after the health-care company's first-quarter results exceeded expectations — and, crucially, its guidance was left mostly intact despite an evolving economic picture. Count us among the investors breathing a sigh of relief. Revenue for the three months ended March 31 declined 1% year over year to $5.74 billion, topping the consensus estimate of $5.59 billion, according to LSEG. Adjusted earnings per share (EPS) totaled $1.88, exceeding the $1.64 estimate, LSEG data showed. On an annual basis, adjusted EPS fell 2.1%. Bottom line Danaher delivered a fairly clean earnings report in a messy, tariff-filled moment — a welcome sign no matter the company. But with the way the once-bankable Danaher has tested our patience and been such a poor-performing stock, Tuesday's results and outlook mean a bit more. Executives also seem to have a handle on minimizing the earnings' impact of tariffs. "It's still g...
[Short citation of 8% of the original article]